| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | CA2446890C Deuterated 3-piperidinopropiophenones and pharmaceutical drugs containing these compounds |
| 02/23/2010 | CA2433021C Isoindole-imide compounds, compositions, and uses thereof |
| 02/23/2010 | CA2400826C Methods and compositions for treating intervertebral disc degeneration |
| 02/23/2010 | CA2378880C Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/18/2010 | WO2010019549A2 Indoprofen derivatives for promoting bone growth |
| 02/18/2010 | WO2010019511A2 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2009137534A3 Estrogenic extracts for use in treating vaginal and vulvar atrophy |
| 02/18/2010 | WO2009129260A3 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 02/18/2010 | WO2009080778A4 Preparations with rosehip extracts, and method of producing rosehip extracts |
| 02/18/2010 | WO2009016451A8 Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound |
| 02/18/2010 | US20100041758 Adhesive preparation |
| 02/18/2010 | US20100041721 Selective androgen receptor modulators |
| 02/18/2010 | US20100041695 Thieno[2,3-b]pyridines as Potassium Channel Inhibitors |
| 02/18/2010 | US20100041675 treatment of retinopathy comprising administering drugs such as tert-butyl 3-[5-ethyl-6-[4-(5,6,7,8-tetrahydro-(1,8)naphthyridin-2-yl)-piperidin-1-yl]-pyrimidin-4-ylamino]-2-(4-methoxy benzoyl)-propionate |
| 02/18/2010 | US20100041654 Pyrimidine Derivatives And Their Use As CB2 Modulators |
| 02/18/2010 | US20100041651 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/18/2010 | US20100041628 Novel indole derivative having ikappab kinase beta inhibitory activity |
| 02/18/2010 | US20100041611 Rapid Isolation of Osteoinductive Protein Mixtures From Mammalian Bone Tissue |
| 02/18/2010 | US20100041606 Methods of Use of Eggshell Polypeptides |
| 02/18/2010 | US20100041599 Compositions and methods for bone formation, bone remodeling and toxin protection |
| 02/18/2010 | US20100041595 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof |
| 02/18/2010 | US20100040686 Biomaterial |
| 02/18/2010 | US20100040662 Fixation Devices For Tissue Repair |
| 02/18/2010 | US20100040630 Methods and compositions for treating bone loss |
| 02/18/2010 | US20100040628 Indoprofen derivatives for promoting bone growth |
| 02/18/2010 | US20100040619 antibodies and antigen binding domains and CDR regions that mediate selective binding to an epitope located in the carboxyl half of the Dkk-1 protein; for bone disorders, inflammatory, neurological, ocular, renal, pulmonary and skin diseases |
| 02/18/2010 | US20100040613 Polypeptide constructs for sublingual administration |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040594 Formulations for nonsurgical exogenous crosslink therapy |
| 02/18/2010 | US20100040593 Formulations for nonsurgical exogenous crosslink therapy |
| 02/18/2010 | US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/17/2010 | EP2153847A1 Gene sensitive to bone/joint disease and use thereof |
| 02/17/2010 | EP2153833A1 ADP-receptor antagonist for treatment of inflammatory disease |
| 02/17/2010 | EP2152753A1 Antibodies against ramp3 |
| 02/17/2010 | EP2152747A2 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 02/17/2010 | EP2152663A2 Tri-aryl compounds and compositions comprising the same |
| 02/17/2010 | EP2152256A2 Telomerase activating compounds and methods of use thereof |
| 02/17/2010 | EP2152254A2 Resveratrol containing composition for modulating bone formation |
| 02/17/2010 | EP1511737B1 Aryloximes |
| 02/17/2010 | EP1451163B1 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
| 02/17/2010 | EP1133560B1 Human parathyroid hormone modifications, preparation and use |
| 02/17/2010 | CN100590124C Tricyclic androgen receptor modulator compounds and method |
| 02/16/2010 | US7662845 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 02/16/2010 | US7662843 Isoxazoline compounds having MIF antagonist activity |
| 02/16/2010 | US7662840 4-{5-[4-(5-Isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine (DW-1350); a leukotriene-B4 receptor antangonist; inhibiting osteoclastic bone absorption |
| 02/16/2010 | US7662830 2-{4-[6-(3-Chloro-4-fluoro-phenyl)-2-morpholin-4-yl-pyrimidin-4-yl]-piperazin-1-yl}-nicotinic acid ethyl ester; 5-Methyl-6-{4-[2-(2-methyl-pyrrolidin-1-yl)-6-phenyl-pyrimidin-4-yl]-piperazin-1-yl}-nicotinic acid; treating conditions related to capsaicin receptor activation; neurophathic pain |
| 02/16/2010 | US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/16/2010 | US7662807 Sulphonated meso-tetraphenyl chlorins |
| 02/16/2010 | US7662633 Method of screening for inhibitors of osteopontin |
| 02/16/2010 | US7662548 Method of screening for modulators of HIV infection |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2429109C Anti-inflammatory agents |
| 02/16/2010 | CA2407043C Naphthamidine urokinase inhibitors |
| 02/16/2010 | CA2402436C Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 02/16/2010 | CA2308551C Phenanthroline derivatives |
| 02/11/2010 | WO2010017102A2 Methods for intracellular modulation of bone morphogenetic protein signaling |
| 02/11/2010 | WO2010017079A1 Oxazole derivatives useful as inhibitors of faah |
| 02/11/2010 | WO2010015792A1 Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors |
| 02/11/2010 | WO2010015520A1 Substituted naphthyridines and use thereof as medicines |
| 02/11/2010 | WO2010015205A1 The use of sophoricoside in preparing medicaments |
| 02/11/2010 | WO2010015090A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 02/11/2010 | WO2009157858A8 Use of cyclolignans for the treatment of a hyperactive immune system |
| 02/11/2010 | US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 02/11/2010 | US20100035929 Unnatural dispyrin analogues, preparation and uses thereof |
| 02/11/2010 | US20100035918 Imidazolone Compounds and Methods of Making and Using the Same |
| 02/11/2010 | US20100035893 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/11/2010 | US20100035885 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 02/11/2010 | US20100035880 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 02/11/2010 | US20100035875 Triazolopyridine jak inhibitor compounds and methods |
| 02/11/2010 | US20100035870 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds |
| 02/11/2010 | US20100035847 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100034901 Animal feed compositions |
| 02/11/2010 | US20100034887 Bursting Pellets |
| 02/11/2010 | US20100034883 Light-curable bone growth material for treating dental bone defects |
| 02/11/2010 | US20100034873 Transdermal ricinoleic acid compositions |
| 02/11/2010 | US20100034868 Scaffolds for the regeneration of cartilage |
| 02/11/2010 | US20100034865 Osteoinductive calcium phosphates |
| 02/11/2010 | US20100034864 Stem cell capture and immobilization coatings for medical devices and implants |
| 02/11/2010 | US20100034823 Crystalline anti-hTNFalpha antibodies |
| 02/11/2010 | US20100034796 Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction |
| 02/11/2010 | CA2732526A1 Oxazole derivatives useful as inhibitors of faah |
| 02/11/2010 | CA2732087A1 Substituted naphthyridines and their use as medicaments |
| 02/10/2010 | EP2151448A1 Glycosylate derivatives of mithramycin, method of preparation and uses thereof |
| 02/10/2010 | EP1525191B1 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 02/10/2010 | EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 02/09/2010 | US7659407 Pharmaceutical compounds |
| 02/09/2010 | US7659367 Contains insulin-like growth factor-I, insulin-like growth factor binding protein 3 and integrin-binding domain of vitronectin ; wound healing; surgical implant, prosthesis, scaffold, wound or burn dressing |
| 02/09/2010 | US7659303 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 02/09/2010 | US7659302 Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 02/09/2010 | US7659299 Compounds inhibiting the binding of sap for treating osteoarthritis |
| 02/09/2010 | US7659293 α-Amino-N-hydroxy-acetamide derivatives |
| 02/09/2010 | US7659280 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
| 02/09/2010 | US7659273 Composition for accelerating bone fracture healing |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |